International Journal of Angiology最新文献

{"title":"Afraid of the Cold: Mitral Valve Replacement in a Patient with Cold Agglutinins.","authors":"Caleb Sokolowski, Joshua S Newman, Daniel Lambert, Stevan S Pupovac, Frank Manetta","doi":"10.1055/s-0044-1801378","DOIUrl":"10.1055/s-0044-1801378","url":null,"abstract":"<p><p>A 40-year-old male presented with symptomatic severe mitral stenosis and moderate mitral insufficiency and was recommended to undergo mitral valve replacement. While undergoing preoperative workup, the patient was found to have positive cold agglutinin (CA) autoantibodies. The patient underwent a successful mechanical mitral valve replacement with maintenance of systemic normothermia and myocardial hypothermia. Postoperatively, no neurologic or thrombotic sequelae were observed and the patient was discharged home with no complications. We propose a management approach to patients with CAs that affords myocardial hypothermia in patients requiring cardiac surgery.</p>","PeriodicalId":13798,"journal":{"name":"International Journal of Angiology","volume":"35 2","pages":"136-138"},"PeriodicalIF":0.8,"publicationDate":"2024-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13171199/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147941378","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Challenges in the Management of Dislodged Coronary Stent Embolization: A Case Report.","authors":"Ozkan Bekler","doi":"10.1055/s-0044-1800844","DOIUrl":"10.1055/s-0044-1800844","url":null,"abstract":"<p><p>Although device embolization is a rare complication in percutaneous coronary interventions (PCI), its mortality and morbidity are serious complications. With the increasing prevalence of complicated procedures, invasive cardiologists encounter device embolization daily. Different devices and techniques are utilized to retrieve these devices. Most devices used during PCIs are infection stents. More infrequently, the tip of diverting wires, angioplasty balloons, or balloon holders may break and embolize distally into the arteries. A 51-year-old man with non-ST elevation myocardial infarction was presented for restoration of the ring of the stent, which was stripped in the first diagonal ostium, with snare communication. The patient had an anterior myocardial infarction and underwent stent implantation in the left anterior descending artery (LAD) 1 month ago. While the stripped stent was being retracted, the LAD stent had been inserted, causing the stent implanted a month ago to be retracted. Additionally, the dissection was observed in the proximal LAD, and the procedure was terminated by stenting the LAD-Diagonal bifurcation lesion using the mini-crush technique. This case report highlights the importance of constant vigilance that invasive cardiologists must show when removing the embolized device. The maturity of the technique depends on the operator's experience with the methods of use and the material possibilities in the laboratory.</p>","PeriodicalId":13798,"journal":{"name":"International Journal of Angiology","volume":"35 2","pages":"125-129"},"PeriodicalIF":0.8,"publicationDate":"2024-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13171191/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147941387","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"High Success Rate in Sealing Distal Coronary Artery Perforations Using Absorbable Gelatin Sponge.","authors":"Arash Hashemi, Alireza Serati, Arsis Ahmadieh, Lida Ghaffari, Mohammad R Movahed","doi":"10.1055/s-0044-1800856","DOIUrl":"10.1055/s-0044-1800856","url":null,"abstract":"<p><p>Coronary artery perforation (CAP) is a major complication of percutaneous coronary intervention (PCI). The management of CAP can be challenging, requiring tailored approaches based on specific clinical scenarios. We are reporting outcome data on six patients who experienced distal CAP during PCI and were 100% successfully treated using absorbable gelatin sponge embolization without procedural or immediate postprocedural complications.</p>","PeriodicalId":13798,"journal":{"name":"International Journal of Angiology","volume":"35 2","pages":"130-135"},"PeriodicalIF":0.8,"publicationDate":"2024-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13171190/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147941371","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Endovascular Repair of Large Iliac Artery Pseudoaneurysm after Remote Transplant Nephrectomy.","authors":"Spyridon Monastiriotis, Taylor Leigh Brezinka, Randall W Franz","doi":"10.1055/s-0044-1793938","DOIUrl":"10.1055/s-0044-1793938","url":null,"abstract":"<p><p>This case study focuses on a 49-year-old woman several years after a right transplant nephrectomy for delayed renal hemorrhage. The patient had an incidental finding of a right external iliac artery pseudoaneurysm measuring 8.1 cm at its largest dimension. Of note, the patient had undergone cardiac catheterization several months prior with right common femoral artery access. This study aimed to implement endovascular repair of posttransplant nephrectomy iliac artery pseudoaneurysms as a less invasive treatment option as compared with open repair in suitable candidates. Percutaneous access of the right common femoral artery with the deployment of a 9 × 50 mm covered stent within the right external iliac artery with the successful exclusion of the pseudoaneurysm. Postoperative course was uncomplicated, and the patient was discharged home on dual antiplatelet therapy. The patient's symptoms completely resolved after the intervention. She underwent follow-up surveillance scans, which redemonstrated a patent external iliac stent and excluded pseudoaneurysm. Endovascular repair with a covered stent for posttransplant nephrectomy iliac artery pseudoaneurysms is a safe, minimally invasive, and valuable treatment option in the absence of underlying infection.</p>","PeriodicalId":13798,"journal":{"name":"International Journal of Angiology","volume":"35 2","pages":"121-124"},"PeriodicalIF":0.8,"publicationDate":"2024-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13171195/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147941397","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Diagnosis and Management of Mitral Valve Disease in the Elderly.","authors":"Preetham Kumar, Surya Aedma, Padmini Varadarajan, Ramdas G Pai","doi":"10.1055/s-0044-1790541","DOIUrl":"10.1055/s-0044-1790541","url":null,"abstract":"<p><p>Calcific mitral stenosis, commonly seen in the elderly in developed countries, occurs primarily due to mitral annular calcification, and its prevalence is increasing secondary to an aging population. Mitral regurgitation, commonly seen across all age groups, occurs primarily due to anatomical or functional impairment of one or more components of the mitral apparatus or the left ventricle that are necessary for normal valve function, and its prevalence is increasing secondary to an increasing number of patients with heart failure. The current review discusses the diagnosis of and treatment options (medical, surgical, and transcatheter) for mitral valve disease, including the associated challenges, specifically in the elderly.</p>","PeriodicalId":13798,"journal":{"name":"International Journal of Angiology","volume":"34 1","pages":"10-22"},"PeriodicalIF":0.9,"publicationDate":"2024-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11813618/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143407438","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A Snapshot on Clinical Trials on Zotarolimus DES: A Repurposing Drug against Myocardial Infarction.","authors":"Vaishali R Undale, Shweta K Lembhe, Shital D Satone, Pratiksha Hase","doi":"10.1055/s-0044-1791556","DOIUrl":"10.1055/s-0044-1791556","url":null,"abstract":"<p><p>Myocardial infarction is the permanent death (necrosis) of heart muscle caused by a lack of oxygen for an extended period of time (ischemia). Since the very first percutaneous transluminal coronary angioplasty was done 40 years ago, the science of interventional cardiology has advanced dramatically. The above progression began with a balloon catheter attached to a fixed wire, advancing to bare-metal stents, first-generation drug-eluting stents (DES), second- and third-generation biodegradable polymer-based DES. Ultimately, bioabsorbable stents are still in development. Zotarolimus is a new pharmacologic therapy with a similar reprint address; for example, the antirestenosis agent sirolimus has recently been investigated as part of a stent platform combined with a biomimetic phosphorylcholine and BioLINX polymer for its biological activity, as well as its usefulness as an antiproliferative agent. Several clinical trials have been conducted to assess the safety and efficacy of the zotarolimus drug-eluting stent (Z-DES). Medtronic Medical Devices, a global leader in medical technology (United States), and Abbot Global Health Care and Research began clinical trials on the Z-DES in 2002 and will continue through 2021 (INDIA). Endeavor (E-Zes), Resolute (R-Zes), Resolute Integrity (I-Zes), and Resolute Onyx are the different forms of Z-DES that Medtronic has tested in clinical trials. In comparison to other DES, Z-DES was found to be safe in these clinical trials done across multiple nations and in a diverse demographic. This review helps understand the overall clinical trial of Z-DES.</p>","PeriodicalId":13798,"journal":{"name":"International Journal of Angiology","volume":"34 1","pages":"23-32"},"PeriodicalIF":0.9,"publicationDate":"2024-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11813614/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143407347","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A Case of the Uncommon Cause of Chronic Coronary Syndrome: Coronary Fistula and Coronary Stenosis, Which One to Intervene?","authors":"Markz R M P Sinurat, Taofan Taofan, Daniel P L Tobing, Celly A Atmadikoesoemah, Sandi Sinurat","doi":"10.1055/s-0044-1791676","DOIUrl":"10.1055/s-0044-1791676","url":null,"abstract":"<p><p>We report a case of chronic coronary syndrome (CCS) that had two completely distinct mechanisms in one patient. We applied comprehensive diagnostic tools using noninvasive and invasive physiology and imaging tests before, during, and after the intervention procedure to evaluate the outcome. The patient had previously visited many physicians and was diagnosed with noncardiac chest pain. He was referred to our department due to the increased frequency and intensity of angina pectoris. After a careful diagnosis, we found a nonsignificant stenosis (50%) in the mid-left anterior descending (mid-LAD) artery and an unexpectedly high-flow coronary artery fistula from the LAD to the main pulmonary artery (MPA). We tried a combination therapy with escalation of the anti-ischemic therapy but failed. He was rehospitalized with unstable angina pectoris. After a comprehensive physiology and imaging test, our team decided to perform fistula embolization with detachable coils and defer stenting in the mid-LAD artery. After the intervention procedure, his angina subsided, and his exercise capacity was remarkably improved. Cardiac computed tomography angiography (CCTA) and cardiac magnetic resonance (CMR) evaluation in 3 months revealed all coils in situ and improved cardiac function. We postulate that comprehensive diagnostic tools are required to select appropriate management and prevent unnecessary procedures.</p>","PeriodicalId":13798,"journal":{"name":"International Journal of Angiology","volume":"35 2","pages":"117-120"},"PeriodicalIF":0.8,"publicationDate":"2024-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13171187/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147941331","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Acute Kidney Injury after Isolated Coronary Bypass Surgery.","authors":"John C Slaughter, Daniel L Davenport, Sibu P Saha","doi":"10.1055/s-0044-1791545","DOIUrl":"10.1055/s-0044-1791545","url":null,"abstract":"<p><p>Acute kidney injury (AKI) is among the most serious of the common postoperative complications of cardiac surgeries, which can increase the short- and long-term morbidity and mortality of patients. This study aimed to examine possible risk factors that lead to AKI. We sought to compare our AKI rates to national averages in coronary artery bypass grafting (CABG) reported by the Society of Thoracic Surgeons (STS). We reviewed our institution's data for renal failure in CABG procedures performed between January 1, 2020, and June 30, 2023. From the database, we identified 1,068 CABG patients and reviewed demographics, nonmodifiable conditions, and modifiable risk factors. The STS database uses the Risk, Injury, Failure, Loss, and End-stage renal disease definition for renal failure. Of our patient sample, 14 (1.3%) experienced renal failure. The national rate for AKI after isolated CABG was 1.9% in 2023. Chronic lung disease was a risk factor for AKI development. The mean perfusion, cross-clamp, ventilator times, and hospital stay increased in AKI patients. All patients who suffered from AKI had undergone perioperative blood transfusion. Our single-center experience with renal failure is slightly better than the national average. In our population, chronic lung disease and lower preoperative ejection fractions were associated with increased rates of AKI. Modifiable risk factors in our population included perioperative blood transfusion and increased perfusion/cross-clamp times. Lastly, AKI patients spent longer time on ventilators, increased lengths of stay, and increased postoperative mortality.</p>","PeriodicalId":13798,"journal":{"name":"International Journal of Angiology","volume":"34 1","pages":"51-55"},"PeriodicalIF":0.9,"publicationDate":"2024-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11813601/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143407430","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A Case of Coronary Artery Aneurysm Occurring After Drug-Coated Balloon Intervention for De Novo Chronic Total Occlusion.","authors":"Pangeran Akbar Syah, Chong Wei Loong, Raditya Dewangga, Kevin Wibawa, I Dewa Gde Dwi Sumajaya, Houng Bang Liew","doi":"10.1055/s-0044-1791675","DOIUrl":"10.1055/s-0044-1791675","url":null,"abstract":"<p><p>Drug-coated balloons (DCBs) have been proposed as a viable alternative to drug-eluting stents (DES) for managing chronic total occlusion (CTO), reducing adverse reactions associated with DES. However, adverse events after DCB treatment are rarely reported. We present a case of coronary artery aneurysm (CAA) formation after DCB treatment. A 55-year-old active smoker presented with exertional chest pain and positive ischemic response on the exercise stress test. Diagnostic coronary angiography revealed CTO in the mid-left anterior descending (mid-LAD) coronary artery with collateral circulation arising from the contralateral side. The patient underwent DCB treatment using a paclitaxel-coated balloon after predilatation with a noncutting balloon and a semi-compliant balloon. The final angiogram showed minimal recoil, type B coronary dissection nonflow limiting, and thrombolysis in myocardial infarction (TIMI) grade 3 flow. A follow-up coronary angiogram at 6 months revealed a fusiform aneurysm at the treated lesion with DCB. Despite the asymptomatic nature of the patient, good distal flow in the LAD, and the patient achieving a TIMI grade 3 flow, a decision was made to observe and closely monitor the patient. Despite potential risks, DCB remains a viable alternative to DES in CTO cases. Our case suggests that, although CAA occurred, it did not lead to significant adverse cardiac events. Further research is needed to understand the predictors and long-term outcomes of CAA.</p>","PeriodicalId":13798,"journal":{"name":"International Journal of Angiology","volume":"35 1","pages":"71-73"},"PeriodicalIF":0.8,"publicationDate":"2024-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12909077/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146213349","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Jetstream Atherectomy with Paclitaxel-Coated Balloons: 3-Year Outcomes of the Prospective Randomized JET-RANGER Study.","authors":"Nicolas W Shammas, Gail Shammas, Sue Jones-Miller","doi":"10.1055/s-0044-1791546","DOIUrl":"10.1055/s-0044-1791546","url":null,"abstract":"<p><p>The JET-RANGER study (NCT03206762) was a multicenter (11 U.S. centers), randomized trial, core-lab adjudicated and designed to demonstrate the superiority of Jetstream + paclitaxel-coated balloon (JET + PCB) versus percutaneous transluminal angioplasty (PTA) + PCB in treating femoropopliteal arterial disease. The 1- and 2-year outcomes have been recently published. The 3-year outcome data are presented in this report. The JET-RANGER trial initially had 47 patients with 48 lesions. Thirty-one in the JET-PCB arm and 16 in the PTA + PCB arm (2:1 randomization). At 3-year follow-ups, there were 20 patients in the JET-PCB arm and 14 patients in the PTA + PCB arm. Kaplan-Meier survival analysis was performed to estimate the freedom from target lesion revascularization (TLR) at 3 years. Bailout stenting was not considered a TLR in this analysis. Statistical significance was determined by a <i>p</i> -value < 0.05. Freedom from TLR was statistically similar between the two groups at 3 years between JET + PCB and PTA + PCB (freedom from TLR was 88.0 vs. 67.8%, respectively, <i>p</i>  = 0.1380). There was also no significant difference in the change of ankle-brachial index (ABI) between the PTA + PCB and JET + PCB from baseline at 6 months ( <i>p</i>  = 0.7890), 1 year ( <i>p</i>  = 0.4070), 2 years ( <i>p</i>  = 0.7410), and 3 years ( <i>p</i>  = 0.8010). There was also no statistical difference between the JET + PCB and PTA + PCB arms for RCC improvement by one or more categories from baseline to 3 years ( <i>p</i>  = 0.8949). There were no minor or major amputations for either arm throughout the 3-year follow-up. Five JET + PCB patients died before the 3-year specified window and none in the PTA + PCB arm ( <i>p</i>  = 0.137). Two of the deaths were due to cancer and three due to cardiac causes. None were deemed related to the device or procedure. JET + PCB had similar freedom from TLR and improvement in ABI and RCC at 3-year follow-up with no difference in amputation or mortality between the 2 arms. A trend toward less TLR was seen in the JET + PCB arm.</p>","PeriodicalId":13798,"journal":{"name":"International Journal of Angiology","volume":"34 1","pages":"56-59"},"PeriodicalIF":0.9,"publicationDate":"2024-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11813604/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143407446","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}